The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Records: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Hyperkeratosis 1
METHYLPREDNISOLONE. Hyperparathyroidism secondary 1
METHYLPREDNISOLONE. Hypersensitivity 1
METHYLPREDNISOLONE. Hypoaesthesia oral 1
METHYLPREDNISOLONE. Hypothermia 1
METHYLPREDNISOLONE. Hypoxic-ischaemic encephalopathy 1
METHYLPREDNISOLONE. Idiopathic pneumonia syndrome 1
METHYLPREDNISOLONE. Ileus 1
METHYLPREDNISOLONE. Ill-defined disorder 1
METHYLPREDNISOLONE. Immune thrombocytopenic purpura 1
METHYLPREDNISOLONE. Increased tendency to bruise 1
METHYLPREDNISOLONE. Infusion site pain 1
METHYLPREDNISOLONE. Injection site extravasation 1
METHYLPREDNISOLONE. Injection site pain 1
METHYLPREDNISOLONE. Injection site swelling 1
METHYLPREDNISOLONE. Interstitial lung disease 1
METHYLPREDNISOLONE. Intra-abdominal pressure increased 1
METHYLPREDNISOLONE. Jaundice 1
METHYLPREDNISOLONE. Joint range of motion decreased 1
METHYLPREDNISOLONE. Keratic precipitates 1

Total Records: 857     Number of Pages: 43